Kura Oncology, Inc.

KURA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001422143

SEC filings (opens in a new tab)

In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Kura Oncology, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of KURA: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	174	1	179	+6
Shares	80.5M	6.97M	82.4M	+8.84M (+12.0%)
Value	$1.66B	$143.4M	$1.61B	+$93.1M (+6.2%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Kura Oncology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to KURA in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	7,155,417	$139.8M	0.00%
Siren, L.L.C.	1,339,942	$26.2M	1.31%
Point72 Asset Management, L.P.	189,103	$3.70M	0.01%
Qube Research & Technologies Ltd	103,069	$2.01M	0.00%
Schroder Investment Management Group	60,847	$1.19M	0.00%
ExodusPoint Capital Management, LP	54,971	$1.07M	0.01%
Cubist Systematic Strategies, LLC	45,927	$897.4K	0.01%
Balyasny Asset Management LLC	33,797	$660.4K	0.00%
Dynamic Technology Lab Private Ltd	30,508	$596.0K	0.06%
ADAR1 Capital Management, LLC	30,000	$586.2K	0.10%
Intech Investment Management LLC	15,257	$298.1K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	13,720	$268.1K	0.05%
Long Corridor Asset Management Ltd	10,000	$195.4K	0.17%
Point72 (DIFC) Ltd	7,483	$146.2K	0.01%
nVerses Capital, LLC	1,300	$25.4K	0.01%
Jaffetilchin Investment Partners, LLC	350	$6.84K	0.00%
Ashton Thomas Securities, LLC	250	$4.88K	0.00%
Clear Street Markets LLC	139	$3.00K	0.00%
Capital Performance Advisors LLP	147	$2.87K	0.00%
True Wealth Design, LLC	110	$2.15K	0.00%
Sterling Capital Management LLC	75	$1.47K	0.00%
National Bank of Canada	1	$20	0.00%

Sold out (16)

Institutions that held Kura Oncology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of KURA in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Artal Group S.A.	1,819,884	$37.5M
Ameriprise Financial Inc	182,557	$3.76M
Integral Health Asset Management, LLC	100,000	$2.06M
Superstring Capital Management LP	36,242	$746.2K
Marshall Wace, LLP	26,267	$540.8K
MYDA Advisors LLC	20,000	$411.8K
Prudential Financial Inc	18,277	$376.3K
Squarepoint Ops LLC	16,319	$336.0K
Capstone Investment Advisors, LLC	13,517	$278.3K
Principal Financial Group Inc	12,492	$257.2K
Engineers Gate Manager LP	12,078	$248.7K
Walleye Trading LLC	747	$15.4K
Pacer Advisors, Inc.	709	$14.6K
Innealta Capital, LLC	54	$1.11K
Main Street Group, LTD	50	$1.06K
Quantbot Technologies LP	14	$288

Not filed for Q3 2024 yet (1)

Institutions that held Kura Oncology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KURA in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	6,965,806	$143.4M